What I find really interesting here is how quickly the market cap went from 100 to 200 million. With all this market exposure, its only going to keep gaining traction in Australia and the US.
But rememebr, the core product is still a world class synthetic antibiotic. We will have even more eyes on Recce 327 now. We still have phase 1 human trials - which as we know it went into a healthy person (a doctor) with no known side effects. And there is a combined Phase1/2 human trial for the topical skin application of it. So much to get excited about!
RCE Price at posting:
$1.35 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)